To verify the ELISA results presented above, we assessed the level of GASP-1 expression from normal tissue samples, BPH tissue samples, and tissue samples of different grades of prostate cancer via immunohistochemical staining with hematoxylin and GASP-1. This evidence concerns the gene GPRASP1 and benign prostatic hyperplasia.